You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 111 No. 11, November 1976 TABLE OF CONTENTS
  Archives
  •  Online Features
  Books
 This Article
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Heparin: Structure. Function and Clinical Implications

edited by Ralph A. Bradshaw and Stanford Wessler, 422 pp, $32.50, New York, Plenum Publishing Corp, 1975.

JACK LINDON, PHD, Reviewer
Boston

Arch Surg. 1976;111(11):1311-1312.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

The papers that comprise this monograph (vol 52 of the Advances in Experimental Medicine and Biology series) were presented at the International Symposium on Heparin held May 13 through 15, 1974, in St Louis. The purpose of this symposium was to bring together scientists and clinicians to share insights into the biochemical properties and clinical applications of heparin. The diverse material is well organized into sections dealing with the drug's structure, function, and clinical uses.

The first section deals with the molecular structure of heparin. X-ray crystallographic and physical chemical data are presented to characterize the basic structure. Biosynthetic pathways are discussed, as are the relationships between fine structure and biological properties. Also included is information on methods of heparin determination and the difficult problem of pharmacologic standardization. The second section deals primarily with the mechanisms of heparin interaction with various components of the coagulation and fibrinolytic pathways. Evidence is . . . [Full Text PDF of this Article]



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1976 American Medical Association. All Rights Reserved.